Suchergebnisse - "Nevoret, Camille"

PubPharm (25)

1

Cardiovascular disease healthcare trajectories : descriptions, similarities, mortality rates of heart failure in France

enthalten in: ESC heart failure | 2024

von Nevoret, C. | Tran, Y. | Guendouz, S. | +4

2

Vitiligo patient population and disease burden in France : VIOLIN study results from the CONSTANCES cohort

enthalten in: Journal of the European Academy of Dermatology and Venereology : JEADV | 2023

von Ezzedine, K. | Seneschal, J. | Da Silva, A. | +8

CommentIn: J Eur Acad Dermatol Venereol. 2023 Nov;37(11):2159-2160. - PMID 37877764

3

The Effectiveness of an App (Insulia) in Recommending Basal Insulin Doses for French Patients With Type 2 Diabetes Mellitus : Longitudinal Observational Study

enthalten in: JMIR diabetes | 2023

von Nevoret, C. | Gervaise, N. | Delemer, B. | +6

4

Correction to : Patterns of Use and Clinical Outcomes with Long-Acting Somatostatin Analogues for Neuroendocrine Tumors: A Nationwide French Retrospective Cohort Study in the Real-Life Setting

enthalten in: Advances in therapy | 2023

von Harrow, B. | Fagnani, F. | Nevoret, C. | +3

ErratumFor: Adv Ther. 2022 Apr;39(4):1754-1771. - PMID 35190997

5

Vitiligo patient population and disease burden in France : VIOLIN study results from the CONSTANCES cohort

enthalten in: Journal of the European Academy of Dermatology and Venereology | 2023

von Ezzedine, K. | Seneschal, J. | Da Silva, A. | +8

6

Management and Health Resource Use of Patients With Metastatic Renal Cell Carcinoma treated With Systemic Therapy Over 2014-2017 in France : A National Real-World Study

enthalten in: Clinical genitourinary cancer | 2022

von Escudier, B. | de Zélicourt, M. | Bourouina, R. | +2

7

Plasma CD27, a Surrogate of the Intratumoral CD27-CD70 Interaction, Correlates with Immunotherapy Resistance in Renal Cell Carcinoma

enthalten in: Clinical cancer research : an official journal of the American Association for Cancer Research | 2022

von Benhamouda, N. | Sam, I. | Epaillard, N. | +28

8

Correction to: Patterns of Use and Clinical Outcomes with Long-Acting Somatostatin Analogues for Neuroendocrine Tumors: A Nationwide French Retrospective Cohort Study in the Real-Life Setting

enthalten in: Advances in therapy | 2022

von Harrow, B. | Fagnani, F. | Nevoret, C. | +3

9

Correction to: Patterns of Use and Clinical Outcomes with Long-Acting Somatostatin Analogues for Neuroendocrine Tumors: A Nationwide French Retrospective Cohort Study in the Real-Life Setting

enthalten in: Advances in therapy | 2022

von Harrow, B. | Fagnani, F. | Nevoret, C. | +3

10

Correction to: Patterns of Use and Clinical Outcomes with Long-Acting Somatostatin Analogues for Neuroendocrine Tumors: A Nationwide French Retrospective Cohort Study in the Real-Life Setting

enthalten in: Advances in therapy | 2022

von Harrow, B. | Fagnani, F. | Nevoret, C. | +3